查看購物車
  • Simplified Chinese
  • English
  • Japanese
  • Korean
封面
市場調查報告書
商品編碼
1578720

糖化血紅素 (HbA1c) 測試 2024 年全球市場報告

Hemoglobin A1c (HbA1c) Testing Global Market Report 2024
出版日期: | 出版商: The Business Research Company | 英文 175 Pages | 商品交期: 2-10個工作天內

價格
簡介目錄

糖化血紅蛋白 (HbA1c) 檢測的市場規模預計在未來幾年將快速成長。 2028年，將以10.6%的複合年成長率成長至27.4億美元。預測期內的預期成長是由於多種因素造成的，文明病的患病率不斷上升，對預防性醫療保健的重視，擴展到新興市場，日益關注個性化醫療和以患者為中心的護理，這是由於支持性監管和報銷政策，遠端醫療和遠端監控方面取得進展。預計推動這一成長的主要趨勢包括技術進步、與數位醫療平台的整合、非侵入性檢測技術的進步、遠端醫療服務的擴展以及遠端患者監護的增強。

糖尿病盛行率的增加預計將推動糖化血紅蛋白 (HbA1c) 檢測市場的擴大。糖尿病是一種慢性疾病，由於胰島素分泌不足或胰島素阻抗，身體難以調節血糖值。糖尿病患者數量的增加是由於不良的飲食習慣，特別是大量食用加工食品和砂糖飲料，以及久坐、體力活動極少的生活方式等因素造成的。此外，老化和遺傳傾向也會增加罹患糖尿病的可能性。 HbA1c 測試對於透過測量過去兩到三個月的平均血糖值來監測長期血糖控制至關重要。例如，根據《柳葉刀》2023年6月的資料，全球糖尿病患者人數預計將從2021年的5.29億增加到2050年的13億。因此，糖尿病盛行率的增加預計將推動 HbA1c 檢測市場的成長。

HbA1c 檢測市場的主要企業正在專注於自動化分析儀的開發，例如使用高效液相層析(HPLC) 技術的分析儀，以提高糖尿病診斷和監測的準確性和效率。基於 HPLC 的解決方案是一種精確測量血液中血紅素變異的先進方法，有助於監測糖尿病患者的長期血糖控制。例如，2021年6月，印度醫療技術公司Trivitron Healthcare Private Limited發布了NANO H5和NANO H110。 NANO H5 是一款緊湊型自動化 HPLC 分析儀，可在 130 秒的處理時間內定量全血中的糖化血紅蛋白 (HbA1c)，提供快速測試結果並同時處理多達 5 個檢體。 NANO H110 也是一款緊湊型自動化 HPLC 分析儀，具有 HbA1c 和 Hb 變異檢測的雙重測試模式。配備條碼掃描器、沖蓋等先進組件，檢體容量高達110個檢體，適合大中型實驗室使用。

目錄

第1章執行摘要

第2章 市場特點

第3章 市場趨勢與策略

第4章宏觀經濟情景

  • 高通膨對市場的影響
  • 烏克蘭與俄羅斯戰爭對市場的影響
  • COVID-19 對市場的影響

第5章世界市場規模與成長

  • 全球糖化血紅蛋白 (HbA1c) 檢測市場：促進因素和限制因素
    • 市場促進因素
    • 市場限制因素
  • 全球糖化血紅蛋白 (HbA1c) 測試市場表現：規模和成長，2018-2023 年
  • 全球糖化血紅蛋白 (HbA1c) 檢測市場預測：規模與成長，2023-2028 年、2033 年

第6章 市場細分

  • 全球糖化血紅蛋白 (HbA1c) 測試市場：按類型、實際和預測分類，2018-2023 年、2023-2028 年、2033 年
  • 基於實驗室的測試
  • 照護現場(POC) 測試
  • 全球糖化血紅蛋白 (HbA1c) 檢測市場：按產品類型、實際和預測，2018-2023、2023-2028、2033
  • 裝置
  • 試劑
  • 套件
  • 全球糖化血紅蛋白 (HbA1c) 檢測市場：按技術、性能和預測分類，2018-2023、2023-2028、2033
  • 免疫檢測
  • 層析法
  • 酵素測定
  • 硼酸鹽親和層析法
  • 高效液相層析
  • 其他
  • 全球糖化血紅蛋白 (HbA1c) 測試市場：按最終用戶、實際和預測，2018-2023、2023-2028、2033
  • 醫院和診所
  • 診斷實驗室
  • 居家醫療
  • 其他

第 7 章 區域/國家分析

  • 全球糖化血紅蛋白 (HbA1c) 檢測市場：按地區、實際和預測，2018-2023、2023-2028、2033
  • 全球糖化血紅蛋白 (HbA1c) 測試市場：按國家、實際和預測，2018-2023、2023-2028、2033

第8章亞太市場

第9章 中國市場

第10章 印度市場

第11章 日本市場

第12章 澳洲市場

第13章 印尼市場

第14章 韓國市場

第15章 西歐市場

第16章英國市場

第17章 德國市場

第18章 法國市場

第19章 義大利市場

第20章 西班牙市場

第21章 東歐市場

第22章 俄羅斯市場

第23章 北美市場

第24章美國市場

第25章加拿大市場

第26章 南美洲市場

第27章 巴西市場

第28章 中東市場

第29章 非洲市場

第30章 競爭格局及公司概況

  • 糖化血紅素 (HbA1c) 檢測市場：競爭格局
  • A1c 血紅素 (HbA1c) 測試市場：公司簡介
    • Roche Holding AG
    • Thermo Fisher Scientific Inc.
    • Abbott Laboratories
    • Danaher Corporation
    • Siemens Healthineers

第31章 其他大型創新企業

  • Tosoh Corporation
  • Hitachi High-Technologies Corporation
  • Beckman Coulter Inc
  • Sysmex Corporation
  • Bio Rad Laboratories Inc
  • ARKRAY Inc
  • Randox Laboratories Ltd
  • Ortho Clinical Diagnostics
  • Agappe Diagnostics Ltd
  • SEKISUI Diagnostics LLC
  • Helena Laboratories
  • Transasia Bio Medicals Ltd
  • EKF Diagnostics
  • Trinity Biotech plc
  • HemoCue AB

第32章競爭基準化分析

第 33 章. 競爭對手儀表板

第34章 重大併購

第35章 未來展望與潛力分析

第36章附錄

簡介目錄
Product Code: r19930

Hemoglobin A1c (HbA1c) testing measures the percentage of hemoglobin with glucose attached, providing an indication of average blood glucose levels over the past 2 to 3 months. It is used to monitor long-term glucose control in diabetic patients and to diagnose diabetes and prediabetes.

The main types of HbA1c testing are laboratory-based testing and point-of-care (PoC) testing. Laboratory-based testing is conducted in a lab setting where blood samples are analyzed using advanced equipment. Product types for this testing include instruments, reagents, kits, and technologies. These technologies encompass immunoassays, chromatography, enzymatic assays, boronate affinity chromatography, high-performance liquid chromatography, and others. End users of HbA1c testing include hospitals and clinics, diagnostic laboratories, homecare settings, and other medical environments.

The hemoglobin A1c (HbA1c) testing market research report is one of a series of new reports from the business research company that provides hemoglobin A1c (HbA1c) testing market statistics, including hemoglobin A1c (HbA1c) testing industry global market size, regional shares, competitors with an hemoglobin A1c (HbA1c) testing market share, detailed hemoglobin A1c (HbA1c) testing market segments, market trends and opportunities, and any further data you may need to thrive in the hemoglobin A1c (HbA1c) testing industry. This hemoglobin A1c (HbA1c) testing market research report delivers a complete perspective of everything you need, with an in-depth analysis of the current and future scenario of the industry.

The hemoglobin A1c (HbA1c) testing market size has grown rapidly in recent years. It will grow from $1.66 billion in 2023 to $1.83 billion in 2024 at a compound annual growth rate (CAGR) of 10.4%. The growth during the historic period can be attributed to several factors, the rising prevalence of diabetes, increased awareness and screening programs, expanding government initiatives and healthcare policies, development of healthcare infrastructure, a growing aging population, improved diagnostic accuracy, and greater adoption of point-of-care testing.

The hemoglobin A1c (HbA1c) testing market size is expected to see rapid growth in the next few years. It will grow to $2.74 billion in 2028 at a compound annual growth rate (CAGR) of 10.6%. The anticipated growth during the forecast period can be attributed to several factors, the rising prevalence of lifestyle diseases, increased emphasis on preventive healthcare, expansion into emerging markets, growing focus on personalized medicine and patient-centric care, supportive regulatory and reimbursement policies, and advancements in telemedicine and remote monitoring. Key trends expected to drive this growth include technological advancements, integration with digital health platforms, progress in non-invasive testing technologies, expansion in telehealth services, and enhancements in remote patient monitoring.

The growing prevalence of diabetes is expected to drive the expansion of the hemoglobin A1c (HbA1c) testing market. Diabetes is a chronic condition where the body struggles to regulate blood glucose levels due to inadequate insulin production or insulin resistance. The rise in diabetes cases is attributed to factors such as poor diet-particularly high consumption of processed foods and sugary drinks-and sedentary lifestyles with minimal physical activity. Additionally, the aging population and genetic predisposition increase the likelihood of developing diabetes. HbA1c testing is essential for monitoring long-term blood glucose control by measuring average blood sugar levels over the past 2-3 months. For example, data from The Lancet in June 2023 projected that global diabetes cases would grow from 529 million in 2021 to 1.3 billion by 2050. Consequently, the increasing prevalence of diabetes will fuel the growth of the HbA1c testing market.

Leading companies in the HbA1c testing market are concentrating on developing automated analyzers, such as those using high-performance liquid chromatography (HPLC) technology, to improve accuracy and efficiency in diabetes diagnosis and monitoring. HPLC-based solutions are advanced methods for precisely measuring hemoglobin variants in blood, which helps in monitoring long-term glucose control in diabetic patients. For instance, in June 2021, Trivitron Healthcare Private Limited, an India-based medical technology company, introduced the NANO H5 and NANO H110. The NANO H5 is a compact, automated HPLC analyzer that quantifies glycated hemoglobin (HbA1c) in whole blood with a processing time of 130 seconds, allowing for rapid laboratory results and the capability to process up to five samples simultaneously. The NANO H110 is another compact, automated HPLC analyzer with dual test modes for both HbA1c and Hb Variant detection. It features advanced components such as a barcode scanner and cap piercing, with a high sample capacity of 110, making it suitable for medium to large laboratories.

In January 2024, Roche Holding AG, a Swiss pharmaceutical and diagnostics company, acquired point-of-care (POC) technology from LumiraDx for $350 million. This acquisition aims to expand Roche's diagnostics portfolio and enhance its capabilities in decentralized healthcare settings, providing quick and reliable tests, including the CE-marked HbA1c test, without requiring specialized storage. LumiraDx is a UK-based company specializing in point-of-care (POC) technology and offering immunoassay and clinical chemistry tests for HbA1c.

Major companies operating in the hemoglobin A1c (HbA1c) testing market are Roche Holding AG, Thermo Fisher Scientific Inc., Abbott Laboratories, Danaher Corporation, Siemens Healthineers, Tosoh Corporation, Hitachi High-Technologies Corporation, Beckman Coulter Inc, Sysmex Corporation, Bio Rad Laboratories Inc, ARKRAY Inc, Randox Laboratories Ltd, Ortho Clinical Diagnostics, Agappe Diagnostics Ltd, SEKISUI Diagnostics LLC, Helena Laboratories, Transasia Bio Medicals Ltd, EKF Diagnostics, Trinity Biotech plc, HemoCue AB, CPC Diagnostics Pvt Ltd, PTS Diagnostics, Menarini Diagnostics srl, Diazyme Laboratories Inc, Osang HealthCare Co Ltd, Eurolyser Diagnostica GmbH, DiaSys Diagnostic Systems GmbH

North America was the largest region in the hemoglobin A1c (HbA1c) testing market in 2023. Asia-Pacific is expected to be the fastest-growing region in the forecast period. The regions covered in the hemoglobin A1c (HbA1c) testing market report are Asia-Pacific, Western Europe, Eastern Europe, North America, South America, Middle East, Africa.

The countries covered in the hemoglobin A1c (HbA1c) testing market report are Australia, Brazil, China, France, Germany, India, Indonesia, Japan, Russia, South Korea, UK, USA, Canada, Italy, Spain.

The hemoglobin A1c (HbA1c) testing market consists of revenues earned by entities by providing services such as home monitoring services, remote patient monitoring solutions, specialized HbA1c assay development, telehealth HbA1c monitoring, and personalized treatment management consulting. The market value includes the value of related goods sold by the service provider or included within the service offering. The hemoglobin A1c (HbA1c) testing market also includes sales of diagnostic reagents, test cartridges, automated analyzers, and calibration standards. Values in this market are 'factory gate' values, that is the value of goods sold by the manufacturers or creators of the goods, whether to other entities (including downstream manufacturers, wholesalers, distributors and retailers) or directly to end customers. The value of goods in this market includes related services sold by the creators of the goods.

The market value is defined as the revenues that enterprises gain from the sale of goods and/or services within the specified market and geography through sales, grants, or donations in terms of the currency (in USD, unless otherwise specified).

The revenues for a specified geography are consumption values that are revenues generated by organizations in the specified geography within the market, irrespective of where they are produced. It does not include revenues from resales along the supply chain, either further along the supply chain or as part of other products.

Hemoglobin A1c (HbA1c) Testing Global Market Report 2024 from The Business Research Company provides strategists, marketers and senior management with the critical information they need to assess the market.

This report focuses on hemoglobin A1c (HbA1c) testing market which is experiencing strong growth. The report gives a guide to the trends which will be shaping the market over the next ten years and beyond.

Reasons to Purchase

  • Gain a truly global perspective with the most comprehensive report available on this market covering 50+ geographies.
  • Understand how the market has been affected by the COVID-19 and how it is responding as the impact of the virus abates.
  • Assess the Russia - Ukraine war's impact on agriculture, energy and mineral commodity supply and its direct and indirect impact on the market.
  • Measure the impact of high global inflation on market growth.
  • Create regional and country strategies on the basis of local data and analysis.
  • Identify growth segments for investment.
  • Outperform competitors using forecast data and the drivers and trends shaping the market.
  • Understand customers based on the latest market shares.
  • Benchmark performance against key competitors.
  • Suitable for supporting your internal and external presentations with reliable high quality data and analysis
  • Report will be updated with the latest data and delivered to you within 3-5 working days of order along with an Excel data sheet for easy data extraction and analysis.
  • All data from the report will also be delivered in an excel dashboard format.

Where is the largest and fastest growing market for hemoglobin A1c (HbA1c) testing ? How does the market relate to the overall economy, demography and other similar markets? What forces will shape the market going forward? The hemoglobin A1c (HbA1c) testing market global report from the Business Research Company answers all these questions and many more.

The report covers market characteristics, size and growth, segmentation, regional and country breakdowns, competitive landscape, market shares, trends and strategies for this market. It traces the market's historic and forecast market growth by geography.

  • The market characteristics section of the report defines and explains the market.
  • The market size section gives the market size ($b) covering both the historic growth of the market, and forecasting its development.
  • The forecasts are made after considering the major factors currently impacting the market. These include:

The impact of sanctions, supply chain disruptions, and altered demand for goods and services due to the Russian Ukraine war, impacting various macro-economic factors and parameters in the Eastern European region and its subsequent effect on global markets.

The impact of higher inflation in many countries and the resulting spike in interest rates.

The continued but declining impact of COVID-19 on supply chains and consumption patterns.

  • Market segmentations break down the market into sub markets.
  • The regional and country breakdowns section gives an analysis of the market in each geography and the size of the market by geography and compares their historic and forecast growth. It covers the growth trajectory of COVID-19 for all regions, key developed countries and major emerging markets.
  • The competitive landscape chapter gives a description of the competitive nature of the market, market shares, and a description of the leading companies. Key financial deals which have shaped the market in recent years are identified.
  • The trends and strategies section analyses the shape of the market as it emerges from the crisis and suggests how companies can grow as the market recovers.

Scope

  • Markets Covered:1) By Type: Laboratory Based Testing; Point Of Care (PoC) Testing
  • 2) By Product Type: Instruments; Reagents; Kits
  • 3) By Technology: Immunoassays; Chromatography; Enzymatic Assays; Boronate Affinity Chromatography; High Performance Liquid Chromatography; Other Technologies
  • 4) By End User: Hospitals And Clinics; Diagnostic Laboratories; Homecare Settings; Other End Users
  • Companies Mentioned: Roche Holding AG; Thermo Fisher Scientific Inc.; Abbott Laboratories; Danaher Corporation; Siemens Healthineers
  • Countries: Australia; Brazil; China; France; Germany; India; Indonesia; Japan; Russia; South Korea; UK; USA; Canada; Italy; Spain
  • Regions: Asia-Pacific; Western Europe; Eastern Europe; North America; South America; Middle East; Africa
  • Time series: Five years historic and ten years forecast.
  • Data: Ratios of market size and growth to related markets, GDP proportions, expenditure per capita,
  • Data segmentations: country and regional historic and forecast data, market share of competitors, market segments.
  • Sourcing and Referencing: Data and analysis throughout the report is sourced using end notes.
  • Delivery format: PDF, Word and Excel Data Dashboard.

Table of Contents

1. Executive Summary

2. Hemoglobin A1c (HbA1c) Testing Market Characteristics

3. Hemoglobin A1c (HbA1c) Testing Market Trends And Strategies

4. Hemoglobin A1c (HbA1c) Testing Market - Macro Economic Scenario

  • 4.1. Impact Of High Inflation On The Market
  • 4.2. Ukraine-Russia War Impact On The Market
  • 4.3. COVID-19 Impact On The Market

5. Global Hemoglobin A1c (HbA1c) Testing Market Size and Growth

  • 5.1. Global Hemoglobin A1c (HbA1c) Testing Market Drivers and Restraints
    • 5.1.1. Drivers Of The Market
    • 5.1.2. Restraints Of The Market
  • 5.2. Global Hemoglobin A1c (HbA1c) Testing Historic Market Size and Growth, 2018 - 2023, Value ($ Billion)
  • 5.3. Global Hemoglobin A1c (HbA1c) Testing Forecast Market Size and Growth, 2023 - 2028, 2033F, Value ($ Billion)

6. Hemoglobin A1c (HbA1c) Testing Market Segmentation

  • 6.1. Global Hemoglobin A1c (HbA1c) Testing Market, Segmentation By Type, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • Laboratory Based Testing
  • Point Of Care (Poc) Testing
  • 6.2. Global Hemoglobin A1c (HbA1c) Testing Market, Segmentation By Product Type, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • Instruments
  • Reagents
  • Kits
  • 6.3. Global Hemoglobin A1c (HbA1c) Testing Market, Segmentation By Technology, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • Immunoassays
  • Chromatography
  • Enzymatic Assays
  • Boronate Affinity Chromatography
  • High Performance Liquid Chromatography
  • Other Technologies
  • 6.4. Global Hemoglobin A1c (HbA1c) Testing Market, Segmentation By End User, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • Hospitals And Clinics
  • Diagnostic Laboratories
  • Homecare Settings
  • Other End Users

7. Hemoglobin A1c (HbA1c) Testing Market Regional And Country Analysis

  • 7.1. Global Hemoglobin A1c (HbA1c) Testing Market, Split By Region, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • 7.2. Global Hemoglobin A1c (HbA1c) Testing Market, Split By Country, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

8. Asia-Pacific Hemoglobin A1c (HbA1c) Testing Market

  • 8.1. Asia-Pacific Hemoglobin A1c (HbA1c) Testing Market Overview
  • Region Information, Impact Of COVID-19, Market Information, Background Information, Government Initiatives, Regulations, Regulatory Bodies, Major Associations, Taxes Levied, Corporate Tax Structure, Investments, Major Companies
  • 8.2. Asia-Pacific Hemoglobin A1c (HbA1c) Testing Market, Segmentation By Type, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • 8.3. Asia-Pacific Hemoglobin A1c (HbA1c) Testing Market, Segmentation By Technology, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • 8.4. Asia-Pacific Hemoglobin A1c (HbA1c) Testing Market, Segmentation By End User, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

9. China Hemoglobin A1c (HbA1c) Testing Market

  • 9.1. China Hemoglobin A1c (HbA1c) Testing Market Overview
  • 9.2. China Hemoglobin A1c (HbA1c) Testing Market, Segmentation By Type, Historic and Forecast, 2018-2023, 2023-2028F, 2033F,$ Billion
  • 9.3. China Hemoglobin A1c (HbA1c) Testing Market, Segmentation By Technology, Historic and Forecast, 2018-2023, 2023-2028F, 2033F,$ Billion
  • 9.4. China Hemoglobin A1c (HbA1c) Testing Market, Segmentation By End User, Historic and Forecast, 2018-2023, 2023-2028F, 2033F,$ Billion

10. India Hemoglobin A1c (HbA1c) Testing Market

  • 10.1. India Hemoglobin A1c (HbA1c) Testing Market, Segmentation By Type, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • 10.2. India Hemoglobin A1c (HbA1c) Testing Market, Segmentation By Technology, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • 10.3. India Hemoglobin A1c (HbA1c) Testing Market, Segmentation By End User, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

11. Japan Hemoglobin A1c (HbA1c) Testing Market

  • 11.1. Japan Hemoglobin A1c (HbA1c) Testing Market Overview
  • 11.2. Japan Hemoglobin A1c (HbA1c) Testing Market, Segmentation By Type, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • 11.3. Japan Hemoglobin A1c (HbA1c) Testing Market, Segmentation By Technology, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • 11.4. Japan Hemoglobin A1c (HbA1c) Testing Market, Segmentation By End User, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

12. Australia Hemoglobin A1c (HbA1c) Testing Market

  • 12.1. Australia Hemoglobin A1c (HbA1c) Testing Market, Segmentation By Type, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • 12.2. Australia Hemoglobin A1c (HbA1c) Testing Market, Segmentation By Technology, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • 12.3. Australia Hemoglobin A1c (HbA1c) Testing Market, Segmentation By End User, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

13. Indonesia Hemoglobin A1c (HbA1c) Testing Market

  • 13.1. Indonesia Hemoglobin A1c (HbA1c) Testing Market, Segmentation By Type, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • 13.2. Indonesia Hemoglobin A1c (HbA1c) Testing Market, Segmentation By Technology, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • 13.3. Indonesia Hemoglobin A1c (HbA1c) Testing Market, Segmentation By End User, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

14. South Korea Hemoglobin A1c (HbA1c) Testing Market

  • 14.1. South Korea Hemoglobin A1c (HbA1c) Testing Market Overview
  • 14.2. South Korea Hemoglobin A1c (HbA1c) Testing Market, Segmentation By Type, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • 14.3. South Korea Hemoglobin A1c (HbA1c) Testing Market, Segmentation By Technology, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • 14.4. South Korea Hemoglobin A1c (HbA1c) Testing Market, Segmentation By End User, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

15. Western Europe Hemoglobin A1c (HbA1c) Testing Market

  • 15.1. Western Europe Hemoglobin A1c (HbA1c) Testing Market Overview
  • 15.2. Western Europe Hemoglobin A1c (HbA1c) Testing Market, Segmentation By Type, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • 15.3. Western Europe Hemoglobin A1c (HbA1c) Testing Market, Segmentation By Technology, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • 15.4. Western Europe Hemoglobin A1c (HbA1c) Testing Market, Segmentation By End User, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

16. UK Hemoglobin A1c (HbA1c) Testing Market

  • 16.1. UK Hemoglobin A1c (HbA1c) Testing Market, Segmentation By Type, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • 16.2. UK Hemoglobin A1c (HbA1c) Testing Market, Segmentation By Technology, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • 16.3. UK Hemoglobin A1c (HbA1c) Testing Market, Segmentation By End User, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

17. Germany Hemoglobin A1c (HbA1c) Testing Market

  • 17.1. Germany Hemoglobin A1c (HbA1c) Testing Market, Segmentation By Type, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • 17.2. Germany Hemoglobin A1c (HbA1c) Testing Market, Segmentation By Technology, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • 17.3. Germany Hemoglobin A1c (HbA1c) Testing Market, Segmentation By End User, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

18. France Hemoglobin A1c (HbA1c) Testing Market

  • 18.1. France Hemoglobin A1c (HbA1c) Testing Market, Segmentation By Type, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • 18.2. France Hemoglobin A1c (HbA1c) Testing Market, Segmentation By Technology, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • 18.3. France Hemoglobin A1c (HbA1c) Testing Market, Segmentation By End User, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

19. Italy Hemoglobin A1c (HbA1c) Testing Market

  • 19.1. Italy Hemoglobin A1c (HbA1c) Testing Market, Segmentation By Type, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • 19.2. Italy Hemoglobin A1c (HbA1c) Testing Market, Segmentation By Technology, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • 19.3. Italy Hemoglobin A1c (HbA1c) Testing Market, Segmentation By End User, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

20. Spain Hemoglobin A1c (HbA1c) Testing Market

  • 20.1. Spain Hemoglobin A1c (HbA1c) Testing Market, Segmentation By Type, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • 20.2. Spain Hemoglobin A1c (HbA1c) Testing Market, Segmentation By Technology, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • 20.3. Spain Hemoglobin A1c (HbA1c) Testing Market, Segmentation By End User, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

21. Eastern Europe Hemoglobin A1c (HbA1c) Testing Market

  • 21.1. Eastern Europe Hemoglobin A1c (HbA1c) Testing Market Overview
  • 21.2. Eastern Europe Hemoglobin A1c (HbA1c) Testing Market, Segmentation By Type, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • 21.3. Eastern Europe Hemoglobin A1c (HbA1c) Testing Market, Segmentation By Technology, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • 21.4. Eastern Europe Hemoglobin A1c (HbA1c) Testing Market, Segmentation By End User, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

22. Russia Hemoglobin A1c (HbA1c) Testing Market

  • 22.1. Russia Hemoglobin A1c (HbA1c) Testing Market, Segmentation By Type, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • 22.2. Russia Hemoglobin A1c (HbA1c) Testing Market, Segmentation By Technology, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • 22.3. Russia Hemoglobin A1c (HbA1c) Testing Market, Segmentation By End User, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

23. North America Hemoglobin A1c (HbA1c) Testing Market

  • 23.1. North America Hemoglobin A1c (HbA1c) Testing Market Overview
  • 23.2. North America Hemoglobin A1c (HbA1c) Testing Market, Segmentation By Type, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • 23.3. North America Hemoglobin A1c (HbA1c) Testing Market, Segmentation By Technology, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • 23.4. North America Hemoglobin A1c (HbA1c) Testing Market, Segmentation By End User, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

24. USA Hemoglobin A1c (HbA1c) Testing Market

  • 24.1. USA Hemoglobin A1c (HbA1c) Testing Market Overview
  • 24.2. USA Hemoglobin A1c (HbA1c) Testing Market, Segmentation By Type, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • 24.3. USA Hemoglobin A1c (HbA1c) Testing Market, Segmentation By Technology, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • 24.4. USA Hemoglobin A1c (HbA1c) Testing Market, Segmentation By End User, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

25. Canada Hemoglobin A1c (HbA1c) Testing Market

  • 25.1. Canada Hemoglobin A1c (HbA1c) Testing Market Overview
  • 25.2. Canada Hemoglobin A1c (HbA1c) Testing Market, Segmentation By Type, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • 25.3. Canada Hemoglobin A1c (HbA1c) Testing Market, Segmentation By Technology, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • 25.4. Canada Hemoglobin A1c (HbA1c) Testing Market, Segmentation By End User, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

26. South America Hemoglobin A1c (HbA1c) Testing Market

  • 26.1. South America Hemoglobin A1c (HbA1c) Testing Market Overview
  • 26.2. South America Hemoglobin A1c (HbA1c) Testing Market, Segmentation By Type, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • 26.3. South America Hemoglobin A1c (HbA1c) Testing Market, Segmentation By Technology, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • 26.4. South America Hemoglobin A1c (HbA1c) Testing Market, Segmentation By End User, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

27. Brazil Hemoglobin A1c (HbA1c) Testing Market

  • 27.1. Brazil Hemoglobin A1c (HbA1c) Testing Market, Segmentation By Type, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • 27.2. Brazil Hemoglobin A1c (HbA1c) Testing Market, Segmentation By Technology, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • 27.3. Brazil Hemoglobin A1c (HbA1c) Testing Market, Segmentation By End User, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

28. Middle East Hemoglobin A1c (HbA1c) Testing Market

  • 28.1. Middle East Hemoglobin A1c (HbA1c) Testing Market Overview
  • 28.2. Middle East Hemoglobin A1c (HbA1c) Testing Market, Segmentation By Type, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • 28.3. Middle East Hemoglobin A1c (HbA1c) Testing Market, Segmentation By Technology, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • 28.4. Middle East Hemoglobin A1c (HbA1c) Testing Market, Segmentation By End User, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

29. Africa Hemoglobin A1c (HbA1c) Testing Market

  • 29.1. Africa Hemoglobin A1c (HbA1c) Testing Market Overview
  • 29.2. Africa Hemoglobin A1c (HbA1c) Testing Market, Segmentation By Type, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • 29.3. Africa Hemoglobin A1c (HbA1c) Testing Market, Segmentation By Technology, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • 29.4. Africa Hemoglobin A1c (HbA1c) Testing Market, Segmentation By End User, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

30. Hemoglobin A1c (HbA1c) Testing Market Competitive Landscape And Company Profiles

  • 30.1. Hemoglobin A1c (HbA1c) Testing Market Competitive Landscape
  • 30.2. Hemoglobin A1c (HbA1c) Testing Market Company Profiles
    • 30.2.1. Roche Holding AG
      • 30.2.1.1. Overview
      • 30.2.1.2. Products and Services
      • 30.2.1.3. Strategy
      • 30.2.1.4. Financial Performance
    • 30.2.2. Thermo Fisher Scientific Inc.
      • 30.2.2.1. Overview
      • 30.2.2.2. Products and Services
      • 30.2.2.3. Strategy
      • 30.2.2.4. Financial Performance
    • 30.2.3. Abbott Laboratories
      • 30.2.3.1. Overview
      • 30.2.3.2. Products and Services
      • 30.2.3.3. Strategy
      • 30.2.3.4. Financial Performance
    • 30.2.4. Danaher Corporation
      • 30.2.4.1. Overview
      • 30.2.4.2. Products and Services
      • 30.2.4.3. Strategy
      • 30.2.4.4. Financial Performance
    • 30.2.5. Siemens Healthineers
      • 30.2.5.1. Overview
      • 30.2.5.2. Products and Services
      • 30.2.5.3. Strategy
      • 30.2.5.4. Financial Performance

31. Hemoglobin A1c (HbA1c) Testing Market Other Major And Innovative Companies

  • 31.1. Tosoh Corporation
  • 31.2. Hitachi High-Technologies Corporation
  • 31.3. Beckman Coulter Inc
  • 31.4. Sysmex Corporation
  • 31.5. Bio Rad Laboratories Inc
  • 31.6. ARKRAY Inc
  • 31.7. Randox Laboratories Ltd
  • 31.8. Ortho Clinical Diagnostics
  • 31.9. Agappe Diagnostics Ltd
  • 31.10. SEKISUI Diagnostics LLC
  • 31.11. Helena Laboratories
  • 31.12. Transasia Bio Medicals Ltd
  • 31.13. EKF Diagnostics
  • 31.14. Trinity Biotech plc
  • 31.15. HemoCue AB

32. Global Hemoglobin A1c (HbA1c) Testing Market Competitive Benchmarking

33. Global Hemoglobin A1c (HbA1c) Testing Market Competitive Dashboard

34. Key Mergers And Acquisitions In The Hemoglobin A1c (HbA1c) Testing Market

35. Hemoglobin A1c (HbA1c) Testing Market Future Outlook and Potential Analysis

  • 35.1 Hemoglobin A1c (HbA1c) Testing Market In 2028 - Countries Offering Most New Opportunities
  • 35.2 Hemoglobin A1c (HbA1c) Testing Market In 2028 - Segments Offering Most New Opportunities
  • 35.3 Hemoglobin A1c (HbA1c) Testing Market In 2028 - Growth Strategies
    • 35.3.1 Market Trend Based Strategies
    • 35.3.2 Competitor Strategies

36. Appendix

  • 36.1. Abbreviations
  • 36.2. Currencies
  • 36.3. Historic And Forecast Inflation Rates
  • 36.4. Research Inquiries
  • 36.5. The Business Research Company
  • 36.6. Copyright And Disclaimer